1. Home
  2. PVLA vs IPI Comparison

PVLA vs IPI Comparison

Compare PVLA & IPI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PVLA
  • IPI
  • Stock Information
  • Founded
  • PVLA 2015
  • IPI 2000
  • Country
  • PVLA United States
  • IPI United States
  • Employees
  • PVLA N/A
  • IPI N/A
  • Industry
  • PVLA Biotechnology: Pharmaceutical Preparations
  • IPI Mining & Quarrying of Nonmetallic Minerals (No Fuels)
  • Sector
  • PVLA Health Care
  • IPI Industrials
  • Exchange
  • PVLA Nasdaq
  • IPI Nasdaq
  • Market Cap
  • PVLA 280.4M
  • IPI 336.4M
  • IPO Year
  • PVLA N/A
  • IPI 2008
  • Fundamental
  • Price
  • PVLA $22.77
  • IPI $38.03
  • Analyst Decision
  • PVLA Strong Buy
  • IPI Sell
  • Analyst Count
  • PVLA 7
  • IPI 2
  • Target Price
  • PVLA $44.43
  • IPI $21.00
  • AVG Volume (30 Days)
  • PVLA 82.1K
  • IPI 236.3K
  • Earning Date
  • PVLA 05-15-2025
  • IPI 05-05-2025
  • Dividend Yield
  • PVLA N/A
  • IPI N/A
  • EPS Growth
  • PVLA N/A
  • IPI N/A
  • EPS
  • PVLA N/A
  • IPI N/A
  • Revenue
  • PVLA N/A
  • IPI $217,865,000.00
  • Revenue This Year
  • PVLA N/A
  • IPI $10.38
  • Revenue Next Year
  • PVLA N/A
  • IPI $2.03
  • P/E Ratio
  • PVLA N/A
  • IPI N/A
  • Revenue Growth
  • PVLA N/A
  • IPI N/A
  • 52 Week Low
  • PVLA $6.20
  • IPI $20.75
  • 52 Week High
  • PVLA $29.27
  • IPI $38.87
  • Technical
  • Relative Strength Index (RSI)
  • PVLA N/A
  • IPI 75.73
  • Support Level
  • PVLA N/A
  • IPI $37.00
  • Resistance Level
  • PVLA N/A
  • IPI $38.86
  • Average True Range (ATR)
  • PVLA 0.00
  • IPI 1.49
  • MACD
  • PVLA 0.00
  • IPI 0.61
  • Stochastic Oscillator
  • PVLA 0.00
  • IPI 91.62

About PVLA Palvella Therapeutics Inc. Common Stock

Palvella Therapeutics Inc is a late clinical-stage biopharmaceutical company committed to serving individuals suffering from serious, rare genetic skin diseases without approved therapies. The Company's lead product candidate, QTORIN 3.9 percent rapamycin anhydrous gel (QTORIN rapamycin), is based on the Company's patented QTORIN platform. QTORIN rapamycin is in clinical development for two rare genetic skin disorders.

About IPI Intrepid Potash Inc

Intrepid Potash Inc produces and sells potash and potash byproducts in three main product segments: Potash, Trio, and Oilfield Solutions. The Potash segment produces and sells potash to the agricultural industry as a fertilizer input, the industrial market as a component of oil and gas drilling fluid, and the animal feed market as a nutrient supplement. The Trio segment produces and sells specialty fertilizer that consists of potassium, sulfate, and magnesium and is mined from langbeinite ore. The oilfield solutions segment offers water, high-speed potassium chloride mixing services, saltwater disposal services, and trucking services. The vast majority of revenue is generated in the United States, which is also the location of the firm's production facilities.

Share on Social Networks: